# Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD

> **NCT05066334** · PHASE2 · RECRUITING · sponsor: **Fondazione Policlinico Universitario Campus Bio-Medico** · enrollment: 52 (estimated)

## Conditions studied

- Intervertebral Disc Degeneration
- Chronic Low-back Pain

## Interventions

- **DRUG:** Autologous BM-MSC
- **PROCEDURE:** Sham

## Key facts

- **NCT ID:** NCT05066334
- **Lead sponsor:** Fondazione Policlinico Universitario Campus Bio-Medico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-22
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2025-05-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05066334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05066334, "Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05066334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*